Following the bioinformatics analysis, we collected 118 HCC patient samples to validate the prognostic role of NEIL3 (Supplementary Table S2) and categorized them into high or low NEIL3 expression group (Figure 2D). The gene discussed is NEIL3; the disease is hepatocellular carcinoma.